Analyst recommendations: Nvidia, On Holding, Duolingo, Target, UnitedHealth…

Every morning, find a selection of analysts' recommendations covering North America. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information can be used to shed light on movements in certain stocks or on market sentiment towards a company.

• Dutch Bros Inc.: William O'Neil & Co Incorporated upgrades to buy from dropped coverage.
• Nvidia Corporation: William O'Neil & Co Incorporated upgrades to buy from dropped coverage.
• On Holding Ag: William O'Neil & Co Incorporated upgrades to buy from dropped coverage.
• Truist Financial Corporation: TD Cowen upgrades to hold from sell with a target price of USD 44.
• Coreweave, Inc.: Morgan Stanley maintains its market weight recommendation and raises the target price from 46 to USD 58.
• Duolingo, Inc.: CITIC Securities Co Ltd maintains its buy recommendation with a price target raised from 357 to USD 590.
• Dxc Technology Company: BMO Capital Markets maintains its market perform recommendation with a price target reduced from 26 to USD 17.
• Dynatrace, Inc.: Loop Capital Markets maintains its hold recommendation with a price target raised from 44 to USD 55.
• Exelixis, Inc.: Citigroup maintains its buy recommendation with a price target raised from USD 45 to USD 56.
• First Solar, Inc.: DZ Bank AG Research maintains its buy recommendation and raises the target price from USD 180 to USD 225.
• New Fortress Energy Inc.: BTIG maintains its buy recommendation and reduces the target price from USD 15 to USD 8.
• Newell Brands Inc.: Zacks maintains a neutral recommendation with a price target raised from 5 to USD 7.
• Nextracker Inc.: BNP Paribas Exane maintains its outperform recommendation and raises the target price from USD 62 to USD 76.
• Nrg Energy, Inc: Jefferies maintains its buy recommendation and raises the target price from USD 132 to USD 187.
• Olin Corporation: Deutsche Bank maintains its hold recommendation and reduces the target price from 32 to USD 24.
• Organon & Co.: Piper Sandler & Co maintains its overweight recommendation and reduces the target price from 24 to USD 18.
• Sarepta Therapeutics, Inc.: Freedom Broker maintains its buy recommendation with a price target reduced from USD 165 to USD 110.
• Target Corporation: RBC Capital maintains its outperform rating and reduces the target price from USD 151 to USD 112.
• Unitedhealth Group Inc.: Barclays maintains its overweight recommendation and reduces the target price from 513 to USD 362.